Albireo Pharma, Inc. (NASDAQ: ALBO) dropped 23.5% to $19.00 after the company reported worse-than-expected Q2 EPS results and filed for a mixed shelf of up to $400 million.
Compass (NYSE:COMP) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Crypto venture funding, which saw a record Q1 in 2022, witnessed the deal pace of Coinbase Ventures slow down in the second quarter, with the total count decreasing 34%, from 71 to 47.